InvestorsHub Logo
Followers 53
Posts 1782
Boards Moderated 0
Alias Born 03/22/2015

Re: fabius post# 18487

Thursday, 09/29/2016 7:06:42 AM

Thursday, September 29, 2016 7:06:42 AM

Post# of 38634
fabius, you are correct



WZ,
just try to abandon - for a moment - your phisician perspective; and just look at the share price perspective.

Even assuming that there could be some issues coming out from the FDA with regards to the blue dye, from now to that moment you still have plenty of catalyst which could push IPCI share price very high.

So, unless the potential IPCI partner has your same assessment, I think you better invest some money in IPCI from now until Christmas.






I didn't just come to these conclusions randomly one day. I was doing proper DD on a stock I was interested in buying. I have no doubt this stock will go up and down many times before Rexista decision is a done deal. Plenty of money to be made here if that's the game you play. But I look for long term fundamentals, and those are weak here. No public HAL studies for Rexista says all I need to know. With Rexista unlikely to get approval with current formulation, there is nothing for PODRAS to enhance, even if future IPCI engineers can get it to work. Generics are a joke- still waiting to hear about Focalin from their partner that no longer exists. Keppra languishes. Most pending ANDA's are late to well-established markets.

Catalysts for this company tend to be rumors on twitter. Not my kind of investment.




Historic note: Until his life's destiny was further clarified, Robin Hood spent several years robbing from the rich and giving to the porcupines. (G. Larson 7/26/82)